Publications by authors named "Herbert Schmid"

40Publications

Radiotherapy and pasireotide treatment of a growth hormone producing pituitary tumor in a diabetic dog.

Can Vet J 2018 10;59(10):1089-1093

Southfields Veterinary Specialists, formerly VRCC, Laindon, United Kingdom (Zublena, Tamborini, North, Lobacz); SeersCroft, North Norsham, United Kingdom (Andrew); University Veterinary Hospital, Dublin, Ireland (Mooney); Department of Clinical Science and Services, The Royal Veterinary College, Herts, United Kingdom (Woolhead, Covey, Church, Niessen); Novartis Institutes for BioMedical Research, Oncology Research, Novartis Pharma AG, Basel, Switzerland (Schmid).

View Article and Find Full Text PDF
October 2018

Ectopic expression of in pancreatic δ cells results in β-like cell neogenesis.

J Cell Biol 2017 12 12;216(12):4299-4311. Epub 2017 Oct 12.

Université Côte d'Azur, Institut National de la Santé et de la Recherche Medicale, Centre National de la Recherche Scientifique, Institut Biologie Valrose, Nice, France

View Article and Find Full Text PDF
December 2017

Pasireotide Therapy of Multiple Endocrine Neoplasia Type 1-Associated Neuroendocrine Tumors in Female Mice Deleted for an Men1 Allele Improves Survival and Reduces Tumor Progression.

Endocrinology 2016 05 18;157(5):1789-98. Epub 2016 Mar 18.

Academic Endocrine Unit (G.V.W., M.S., B.S.S., K.E.L., R.V.T.), Radcliffe Department of Medicine, Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), University of Oxford, Churchill Hospital, Oxford, OX3 7LJ, United Kingdom; Nuffield Department of Surgical Sciences (G.V.W., B.S.S.), University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DU, United Kingdom; Department of Endocrinology (A.B.G.), OCDEM, Churchill Hospital, Oxford, OX3 7LJ, United Kingdom; and Novartis Pharma AG (H.A.S.), Novartis Institutes for Biomedical Research, Oncology, CH-4057 Basel, Switzerland.

View Article and Find Full Text PDF
May 2016

Somatostatin receptor activation is involved in the control of daily torpor in a seasonal mammal.

Am J Physiol Regul Integr Comp Physiol 2015 Sep 8;309(6):R668-74. Epub 2015 Jul 8.

Rowett Institute for Nutrition and Health, Aberdeen, United Kingdom; and.

View Article and Find Full Text PDF
September 2015

SOM230: a new therapeutic modality for Cushing's disease.

Chimia (Aarau) 2014 ;68(7-8):483-4

Global Discovery Chemistry Novartis Institutes of Biomedical Research CH-4002 Basel, Switzerland.

View Article and Find Full Text PDF
May 2015

Ultra-rapid growth of biphasic nanowires in micro- and hypergravity.

Small 2013 Apr 13;9(7):1042-6. Epub 2012 Dec 13.

Leibniz Institute for New Materials, CVD/Biosurfaces, Saarbruecken, Germany.

View Article and Find Full Text PDF
April 2013

Effects of somatostatin analogs on glucose homeostasis in rats.

J Endocrinol 2012 Jan 10;212(1):49-60. Epub 2011 Oct 10.

Novartis Pharma AG, Novartis Institutes for Biomedical Research, Oncology, CH-4057 Basel, Switzerland.

View Article and Find Full Text PDF
January 2012

Somatostatin receptors in non-neuroendocrine malignancies: the potential role of somatostatin analogs in solid tumors.

Future Oncol 2011 Jul;7(7):895-913

Novartis Pharma AG, Forum 1, Novartis Campus, CH-4056 Basel, Switzerland.

View Article and Find Full Text PDF
July 2011

Preclinical evaluation of Som230 as a radiation mitigator in a mouse model: postexposure time window and mechanisms of action.

Radiat Res 2011 Jun 29;175(6):728-35. Epub 2011 Apr 29.

Division of Radiation Health, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA.

View Article and Find Full Text PDF
June 2011

Effect of SOM230 (pasireotide) on corticotropic cells: action in dogs with Cushing's disease.

Neuroendocrinology 2011 28;94(2):124-36. Epub 2011 Apr 28.

Unidad de Endocrinología, Hospital Escuela, Facultad de Ciencias Veterinarias, Universidad de Buenos Aires, Buenos Aires, Argentina.

View Article and Find Full Text PDF
January 2012

Differential ligand-mediated pituitary somatostatin receptor subtype signaling: implications for corticotroph tumor therapy.

J Clin Endocrinol Metab 2009 Nov 9;94(11):4342-50. Epub 2009 Oct 9.

Department of Medicine, Pituitary Center, Cedars SinaiMedical Center, Los Angeles, California 90048, USA.

View Article and Find Full Text PDF
November 2009

New perspective in peptide chemistry by N-alkylation.

Adv Exp Med Biol 2009 ;611:229-31

Department Chemie, Lehrstuhl II für Organische Chemie, Technische Universität München, Lichtenbergstrasse 4, Garching 85747, Germany.

View Article and Find Full Text PDF
June 2009

Differential effects of octreotide and pasireotide on somatostatin receptor internalization and trafficking in vitro.

J Clin Endocrinol Metab 2009 Feb 11;94(2):654-61. Epub 2008 Nov 11.

Department of Pharmacology and Toxicology, Otto-von-Guericke-University, Magdeburg, Germany.

View Article and Find Full Text PDF
February 2009

Pasireotide (SOM230): development, mechanism of action and potential applications.

Authors:
Herbert A Schmid

Mol Cell Endocrinol 2008 May 19;286(1-2):69-74. Epub 2007 Sep 19.

Novartis Institutes for BioMedical Research, Oncology Research, Novartis Pharma AG, Basel, Switzerland.

View Article and Find Full Text PDF
May 2008

Regulation of ghrelin secretion by somatostatin analogs in rats.

Eur J Endocrinol 2005 Jun;152(6):887-94

Novartis Institutes for Biomedical Research, Basel, Switzerland.

View Article and Find Full Text PDF
June 2005

Functional activity of the multiligand analog SOM230 at human recombinant somatostatin receptor subtypes supports its usefulness in neuroendocrine tumors.

Neuroendocrinology 2004 ;80 Suppl 1:47-50

Novartis Institutes for Biomedical Research, Novartis Pharma AG, Oncology and Neuroscience Research, WSJ.386.425, Basel, Switzerland.

View Article and Find Full Text PDF
December 2004

Opportunities in somatostatin research: biological, chemical and therapeutic aspects.

Nat Rev Drug Discov 2003 Dec;2(12):999-1017

Transplantation and Immunology, Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4002 Basel, Switzerland.

View Article and Find Full Text PDF
December 2003

Site-specific effects of ghrelin on the neuronal activity in the hypothalamic arcuate nucleus.

Neurosci Lett 2003 May;341(2):151-5

Institute of Veterinary Physiology, University of Zurich, Winterthurerstrasse 260, 8057, Zurich, Switzerland.

View Article and Find Full Text PDF
May 2003

Amylin and glucose co-activate area postrema neurons of the rat.

Neurosci Lett 2002 Aug;328(2):121-4

Max-Planck-Institute for Physiological and Clinical Research, W.G. Kerckhoff-Institute, 61231, Bad Nauheim, Germany.

View Article and Find Full Text PDF
August 2002